Related Experiment Videos
Bile acids--what's new
1Tufts University School of Veterinary Medicine, North Grafton, MA 01536, USA.
Seminars in Veterinary Medicine and Surgery (Small Animal)
|February 1, 1997
Summary
Elevated bile acids indicate liver disease in cats. Ursodeoxycholate may help by replacing toxic bile acids and offering protective effects for hepatobiliary disorders.
Area of Science:
- Veterinary Medicine
- Hepatology
- Toxicology
Background:
- Elevated serum and tissue bile acid concentrations are characteristic of hepatobiliary disease.
- Serum bile acid testing is a sensitive and specific diagnostic tool for acquired hepatobiliary disease and congenital portosystemic shunts in felines.
- High bile acid concentrations are cytotoxic and may contribute to the progression of liver disorders.
Purpose of the Study:
- To investigate the potential therapeutic role of ursodeoxycholate in managing feline hepatobiliary disorders.
- To explore how ursodeoxycholate may ameliorate the harmful effects of hepatotoxic bile acids.
Main Methods:
- Oral administration of ursodeoxycholate.
- Assessment of changes in the circulating bile acid pool.
- Evaluation of ursodeoxycholate's choleretic and immunomodulatory effects.
Main Results:
- Ursodeoxycholate, a less hydrophobic bile acid, can displace more toxic bile acids from circulation.
- This displacement may mitigate the cytotoxic effects of endogenous hepatotoxic bile acids.
- Ursodeoxycholate exhibits choleretic and immunomodulatory properties.
Conclusions:
- Oral ursodeoxycholate shows promise in managing feline hepatobiliary disease.
- Its mechanism involves altering the bile acid pool composition and exerting direct protective effects.
- Further research into ursodeoxycholate's therapeutic benefits in veterinary hepatology is warranted.